Jidong Xiao1, Yuanquan Zhou1, Wenhui Zhu1. 1. Department of Diagnostic Ultrasound, Third Xiangya Hospital, Central South University Changsha City 410013, Hunan Province, China.
Abstract
INTRODUCTION: Nasopharyngeal carcinoma-associated gene 6 (NGX6) is a newly discovered tumor suppressor gene. It contains one epidermal growth factor (EGF)-like domain. Many studies have shown that proteins contain (EGF)-like domain structure affect a variety of biological actions. However, little is known about the relationships between NGX6 expression and biological behaviors in invasive ductal breast carcinoma (IDBC). The study discussed the association of ultrasonographic features with NGX6 expression and prognosis in IDBC. METHODS: Ultrasonographic feature and clinical data in 122 patients with IDBC were retrospectively analyzed. NGX6 expression of IDBC was measured using immunohistochemistry methods. RESULTS: The incidence of the burr sign, lymph node metastasis and abundance blood flow in NGX6 expression negative groups were higher than those in positive groups. Kaplan-Meier analysis showed that the association between NGX6 positive expression and higher disease-free survival (DFS) or higher overall survival (OS); Lymph node metastasis is associated with lower DFS or lower OS; Lower blood flow grade is associated with higher DFS. In univariate and multivariate survival analysis, NGX6 expression, lymph node metastasis, TNM and the blood flow grade were the independent prognostic factors for DFS and OS of IDBC. CONCLUSIONS: ultrasonographic features are associated with NGX6 expression in IDBC. NGX6 is involved in the invasion and metastasis activity of IDBC. Our results suggest that NGX6 may be employed as a promising prognostic factor and useful therapeutic target for IDBC. Combination of ultrasonic findings and NGX6 detection may yield clinically useful information for IDBC prognosis.
INTRODUCTION: Nasopharyngeal carcinoma-associated gene 6 (NGX6) is a newly discovered tumor suppressor gene. It contains one epidermal growth factor (EGF)-like domain. Many studies have shown that proteins contain (EGF)-like domain structure affect a variety of biological actions. However, little is known about the relationships between NGX6 expression and biological behaviors in invasive ductal breast carcinoma (IDBC). The study discussed the association of ultrasonographic features with NGX6 expression and prognosis in IDBC. METHODS: Ultrasonographic feature and clinical data in 122 patients with IDBC were retrospectively analyzed. NGX6 expression of IDBC was measured using immunohistochemistry methods. RESULTS: The incidence of the burr sign, lymph node metastasis and abundance blood flow in NGX6 expression negative groups were higher than those in positive groups. Kaplan-Meier analysis showed that the association between NGX6 positive expression and higher disease-free survival (DFS) or higher overall survival (OS); Lymph node metastasis is associated with lower DFS or lower OS; Lower blood flow grade is associated with higher DFS. In univariate and multivariate survival analysis, NGX6 expression, lymph node metastasis, TNM and the blood flow grade were the independent prognostic factors for DFS and OS of IDBC. CONCLUSIONS: ultrasonographic features are associated with NGX6 expression in IDBC. NGX6 is involved in the invasion and metastasis activity of IDBC. Our results suggest that NGX6 may be employed as a promising prognostic factor and useful therapeutic target for IDBC. Combination of ultrasonic findings and NGX6 detection may yield clinically useful information for IDBC prognosis.
Entities:
Keywords:
Invasive ductal breast carcinoma (IDBC); NGX6; prognosis; ultrasonography
Authors: Therese B Bevers; Benjamin O Anderson; Ermelinda Bonaccio; Saundra Buys; Sandra Buys; Mary B Daly; Peter J Dempsey; William B Farrar; Irving Fleming; Judy E Garber; Randall E Harris; Alexandra S Heerdt; Mark Helvie; John G Huff; Nazanin Khakpour; Seema A Khan; Helen Krontiras; Gary Lyman; Elizabeth Rafferty; Sara Shaw; Mary Lou Smith; Theodore N Tsangaris; Cheryl Williams; Thomas Yankeelov; Thomas Yaneeklov Journal: J Natl Compr Canc Netw Date: 2009-11 Impact factor: 11.908
Authors: Liyu Jiang; Tingting Ma; Meena S Moran; Xiaoli Kong; Xiaoyan Li; Bruce G Haffty; Qifeng Yang Journal: Anticancer Res Date: 2011-06 Impact factor: 2.480
Authors: Jung Min Chang; In Ae Park; Su Hyun Lee; Won Hwa Kim; Min Sun Bae; Hye Ryoung Koo; Ann Yi; Seung Ja Kim; Nariya Cho; Woo Kyung Moon Journal: Eur Radiol Date: 2013-05-15 Impact factor: 5.315
Authors: Jos A van der Hage; J Sven D Mieog; Cornelis J H van de Velde; Hein Putter; Harry Bartelink; Marc J van de Vijver Journal: Breast Cancer Res Date: 2011-06-24 Impact factor: 6.466